Abstract | PURPOSE: METHODS: Chronic gastric lesions were induced in male Sprague-Dawley rats with acetic acid. OA was administered orally during 14 days at 25, 50 and 100 mg/kg per day. Ranitidine (50 mg/kg) and the vehicle were used as controls. The ulcer area (mm2) and the curative ratio (%) were determined. Histological preparations were carried out for comparative purposes. RESULTS: The effect of OA was significantly different as compared to the control reducing the lesion area (in mm2) from 39+/-7 in controls to 17.8+/-1.9 and 9.4+/-1.1 at the doses of 50 and 100 mg/kg, respectively. The curative ratio was 54.5 and 76% for the compound at 50 and 100 mg/kg, while ranitidine at 50 mg/kg reduced the lesion area to 6.9+/-0.8 with a curative ratio of 84%. Mucosal thickness increased from 342 microm in controls to 540 microm in oleanolic acid- (100 mg/kg) and 945 microm in ranitidine-treated animals. Histological examination of the stomach showed regeneration of the lesions. CONCLUSIONS: OA improves healing of chronic gastric lesions in rats. The low toxicity and widespread occurrence of OA in plants suggest a potential for the development of the triterpene or their derivatives as a new antiulcer drug.
|
Authors | Jaime A Rodríguez, Luis Astudillo, Guillermo Schmeda-Hirschmann |
Journal | Pharmacological research
(Pharmacol Res)
Vol. 48
Issue 3
Pg. 291-4
(Sep 2003)
ISSN: 1043-6618 [Print] Netherlands |
PMID | 12860449
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Histamine H2 Antagonists
- Plant Extracts
- Oleanolic Acid
- Ranitidine
- Acetic Acid
|
Topics |
- Acetic Acid
- Analysis of Variance
- Animals
- Gastric Mucosa
(physiopathology)
- Histamine H2 Antagonists
(therapeutic use)
- Male
- Oleanolic Acid
(therapeutic use)
- Phytotherapy
- Plant Extracts
(therapeutic use)
- Ranitidine
(therapeutic use)
- Rats
- Rats, Sprague-Dawley
- Solanaceae
- Stomach Ulcer
(chemically induced, drug therapy)
|